Why physicians join our ophthalmology community
Sermo’s ophthalmology physician network provides practicing ophthalmologists with a secure, peer-driven platform to discuss the latest in surgical techniques, retinal therapeutics, glaucoma management, and anterior segment disorders. Whether you’re a retina specialist, a refractive surgeon, or managing general eye care, Sermo connects you to peers facing similar challenges—from reimbursement for new procedures to managing post-operative complications, treatment adherence, and rapidly shifting patient expectations for visual outcomes.
Earn money sharing your ophthalmology expertise
Learn why surveys are worth it for ophthalmologists and tackle topics such as:
- Surveys on the adoption of MIGS (Minimally Invasive Glaucoma Surgery)
- Opinion polls on preferred anti-VEGF agents
- Research studies around dry eye disease management protocols

Access ophthalmology drug insights from peers
Get practical, peer-reviewed information on ophthalmic treatments and technologies:
- Detailed safety profiles of intravitreal injections and topical therapies
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new devices and practical use cases

Learn from ophthalmology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Discussing surgical risks and benefits with cataract patients
- Showing empathy in diagnoses of progressive vision loss
- Barriers to adherence for daily glaucoma drops
- Emerging gene therapies for inherited retinal diseases

Hear from fellow physician peers
Excellent resource when I don’t have too much experience with a certain drug
Sermo is an excellent tool for connecting colleagues and often helps us share our experiences and clarify diagnostic and therapeutic doubts.
Sermo is a great place to read new cases and bring updated medical news and trends. It’s a great place to interact and a great place to participate in surveys and earn money.
Frequently asked questions
Sermo’s ophthalmology community regularly shares updates and discussions around FDA approvals, trial outcomes, and real-world experiences with new implants, drops, and surgical devices.
Yes. Our drug ratings feature allows ophthalmologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for conditions like AMD and diabetic retinopathy, as well as recruitment challenges.
Yes. Whether you are focused on vitreoretinal surgery, cornea, or medical management of glaucoma, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from diagnostic dilemmas in neuro-ophthalmology to surgical videos and management of post-op complications.
Yes. Many discussions focus on coding, reimbursement for new procedures, and the business side of running an ophthalmology practice.
Sermo enables real-time collaboration. Post a case anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your ophthalmology journey on Sermo
Become part of a dynamic ophthalmology physician network of over 36,000 members dedicated to preserving vision and advancing eye care through peer collaboration and expert insights.



